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ABSTRACT
Background and Objectives: It is essential to minimize
pain after laparoscopic surgery. This study examined the
effect of wound infiltration by a long-acting local anes-
thetic.
Methods: This prospective, randomized study includes
190 laparoscopic procedures carried out by the same sur-
geon. The patients were randomly allocated into 2
groups. The control group comprised 75 cases of laparo-
scopic cholecystectomy (LC) and 20 cases of laparoscop-
ic inguinal hernia repair (LIHR) without the use of a local
anesthetic; only saline was used. The study group com-
prised 75 cases of LC and 20 cases of LIHR with preinci-
sional periportal infiltration with 20 mL of ropivacaine
(10 mg/mL). The postoperative pain scores at 3, 6, 12,
and 24 hours determined with a visual analogue scale
(VAS), nausea, and the kind and amount of analgesic
drugs were assessed.
Results: In the study group in 41% of LC cases and 85% of
LIHR cases, no analgesia was required at all; likewise, in the
control group in 20% of LC cases and 44% of LIHR cases, no
analgesia was required. The difference was statistically signif-
icant (P<0.05). In the remainder, pain at 3 and 6 hours and
total analgesic requirements in the study group were less than
that in the control group (P<0.05). The postoperative nausea
and shoulder pain remained statistically unchanged (P>0.05).
Conclusions: It seems that wound infiltration with ropi-
vacaine in laparoscopy provides satisfactory postopera-
tive analgesia, diminishing or reducing the need for opi-
oids.
Key Words: Laparoscopy, Laparoscopic cholecystecto-
my, Hernia repair, Local anesthesia, Analgesia,
Ropivacaine.
INTRODUCTION
It is well known that laparoscopy causes less postopera-
tive pain than does open cholecystectomy,1,2 as do other
laparoscopic procedures, eg, inguinal hernia repair.3,4
However, it is not completely painless.5 This pain is
thought to be multifactorial in nature and severity, and
various methods of analgesia have been introduced.
They aim at avoidance of opioids and include nons-
teroidal antiinflammatory drugs (NSAIDs), intraperitoneal
local anesthesia,6 local anesthetic infiltration of the
wound,7 intraperitoneal saline,8 adequate removal of the
insufflation gas, heated gas, low pressure gas,9 and
nitrous oxide pneumoperitoneum. The combination of
techniques that have parietal, diaphragmatic, and viscer-
al components may reduce pain after laparoscopy. The
accurate assessment of pain is difficult because of its
individual threshold, subjectivity, and difficulty in meas-
urement. However, most of all, the prevention of pain
should be directed peripherally at inputs along sensory
axons or central neurons.10 Preincisional or preemptive
analgesia with long-acting local anesthesia theoretically
achieves peripheral blockage of pain stimuli, which is
more advantageous than treating pain after it occurs.
However, little is known about preemptive infiltration of
trocar sites by local anesthetics. It is postulated that this
reduces postoperative pain and analgesic requirements.
Bupivacaine has been used recently for somatovisceral
blockage with satisfactory results.11-13 In this prospective,
randomized trial, we chose ropivacaine, a long-acting
(duration 8 to 10 hours) local anesthetic, because of its
postulated safety and theoretical improved efficacy. The
purpose was to evaluate the analgesic effect of preinci-
sional port-site wound infiltration in reducing postopera-
tive pain after laparoscopic procedures in comparison
with placebo use.
MATERIALS AND METHODS
This prospective, randomized trial was designed to
include 190 laparoscopic procedures (150 cholecystec-
tomies and 40 inguinal hernia repairs) carried out by the
same surgeon. It conforms to CONSORT guidelines for
the reporting of clinical trials. Ethical approval by the sci-
entific committee of our hospital was achieved as was
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written consent from the patients. Patients were random-
ly allocated into 2 groups. The randomization was con-
ducted by sealed envelope on the patient’s arrival at the
operating theater until the planned number of equivalent
groups was reached. An independent surgeon was
responsible for the randomization as well as for the
preparation of an unmarked syringe containing 20 mL of
ropivacaine or saline. The operating surgeon, the staff,
and the patients were blinded to this procedure. In the
control group including 75 cases of LC and 20 cases of
LIHR, wound infiltration with local anesthetic was not
used; only saline was used. In the study group including
75 cases of LC and 20 cases of LIHR, preincisional peri-
portal infiltration with ropivacaine was applied. The
patients belonged to ASA II or I, according to the classi-
fication of the American Society of Anesthesiologists.
Patients with a previous upper abdominal operation or
suspected bile duct stones by ultrasonography and liver
function tests were excluded from laparoscopic cholecy-
stectomy; those with a previous lower abdominal opera-
tion, except of appendectomy, were excluded from
laparoscopic hernia repair.
Similar anesthetic and operative techniques were applied
in all patients. Patients were premedicated with oral
diazepam 0.15 mg/kg 1 hour before the operation. All
patients received an intravenous injection of midazolam 2
mg and ondansetron 4 mg just before the anesthesia.
General anesthesia with an endotracheal tube was
achieved by using fentanyl 3 to 5 µg/kg and propofol 2
to 3 mg/kg followed by cisatracurium 0.1 mg/kg and
sevoflurane to maintain it. Pneumoperitoneum was
achieved by insertion under direct vision of a special
cone-shaped trocar 10 to 12 mm (Ethicon, Cincinnati,
OH, USA) through the infraumbilical region (Hasson
open method) and insufflation of warmed carbon diox-
ide. This first trocar was used for the introduction of an
optic direct view 0° for cholecystectomy and oblique
view 30° for hernia repair.
Intraabdominal pressure was maintained at 12 mm Hg for
cholecystectomy and at 16 mm Hg for hernia repair.
Before the skin incision and trocar placement, local infil-
tration of the port sites throughout all layers with 20 mL
ropivacaine (Astra, Södertälje, Sweden) containing 10
mg/mL (study group) or saline (control group) was per-
formed. The local anesthetic or saline was equally allo-
cated according to the diameter of the trocar; 7 mL for 10
to 12 mm and 3 mL for 5 mm.
Laparoscopic cholecystectomy was performed with the
patient in a slight reverse Trendelenburg position with a
4-trocar technique, according to the “American’’ variable.
Hernia repair was performed with the patient in the
opposite position (slight Trendelenburg) with a 3-trocar
technique. The hernia repair was achieved by a transab-
dominal preperitoneal (TAPP) approach and placement
of a 6 x 11-cm polypropylene mesh (Prolene, Ethicon,
Cincinnati, OH, USA) under the transversalis fascia to
reinforce the posterior wall. It was secured at the site
with titanium clips.
A drain was not used in any case. Antibiotic prophylaxis
was attempted with 3 doses of a second-generation
cephalosporin.
An independent nurse recorded the postoperative pain at
the 3rd, 6th, 12th, and 24th hour after the operation
according to patient’s perception. The randomization
was blind to both of them. Pain assessment was based
on a 0 to 10 visual analogue scale (VAS, 0: no pain, 10:
the worst imaginable pain). Preoperatively, the nurse
introduced patients to the concept of a VAS scale. If the
VAS score was above 3, an intramuscular (IM) injection
of diclofenac 75 mg was applied. If pain was persistent,
an IM injection of dextropropoxyphene 75 mg at first,
and then if this was inadequate meperidine 50 mg was
administered.
Postoperative nausea and shoulder pain were noted. The
nausea was assessed by the patient’s complaint and the
need for the use of an antiemetic drug.
Parametric data were compared between groups by
analysis of variances (ANOVA) and post-hoc testing.
Statistical significance was assumed if P<0.05.
Nonparametric data were analyzed with chi-square tests
between groups. The analysis was performed with the
Statistical Package for the Social Sciences (SPSS, Inc.,
Chicago, IL, USA).
RESULTS
Cholecystectomy was performed in the control group in
14 men and 61 women with a mean age of 55 years
(range 22 to 82) and in the study group in 16 men and
59 women with a mean age of 56 years (range 17 to 88),
suffering from symptomatic cholelithiasis. Inguinal her-
nia repair was performed in the control group in 16
patients including 14 men and 2 women with a mean age
of 58 years (range 33 to 71), in which the hernia wasbilateral in 4 cases and recurrent in 5 cases. It was per-
formed in the study group in 14 patients including 13
men and 1 woman with a mean age of 60 years (range
35 to 72), in which the hernia was bilateral in 6 cases and
recurrent in 6 cases.
The laparoscopic procedure was completed successfully
in all cases without any intraoperative complications or
need of conversion to an open operation.
The mean duration of the operation was 47 minutes
(range 25 to 90) for cholecystectomy and 40 minutes
(range 25 to 65) for hernia repair in the study group. It
was 50 minutes (range 35 to 85) for LC and 45 minutes
(range 30 to 90) for LIHR in the control group.
No cardiotoxicity, neurotoxicity or any other toxic effect
was associated with the local use of ropivacaine. All but
4 patients recovered well and had an uneventful postop-
erative course without any complications or death. In 3
cases (2 in the study and 1 in the control group), after
laparoscopic cholecystectomy (morbidity 1.5%), an ultra-
sound revealed mild infrahepatic bile collection (biloma)
manifested by persistent right upper quadrant pain, fever,
and leukocytosis. It was managed successfully by
drainage under ultrasound guidance and antibiotics. In 1
case in the study group, after laparoscopic bilateral repair
of a large recurrent inguinal hernia, moderate scrotal
swelling was seen due to right spermatic cord edema. It
was resolved in a few weeks.
Postoperative analgesia was not required in the study
group in 31 patients after LC (41%) and in 12 patients
after LIHR (85%); in the control group in 15 patients after
LC (20%) and in 7 patients after LIHR (44%). The differ-
ences were statistically significant (P<0.05). The VAS
scores in the study group were significantly lower than
those in the control group at the 3rd and 6th hours
(P<0.01), whereas they did not differ significantly at the
12th and 24th hours (P>0.05) (Figures 1 and 2).
Shoulder pain was experienced in the study group in 20
patients after LC (27%) and in 1 patient after LIHR (7%);
in the control group in 22 patients after LC (30%) and in
2 patients after LIHR (12%). The differences were not sta-
tistically significant (P>0.05). The pain was managed with
diclofenac, a nonsteroidal antiinflammatory drug.
Opioids were used in the study group in 24 patients after
LC (32%) and in 1 patient after LIHR (7%); in the control
group in 36 patients after LC (51%) and in 8 patients after
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LIHR (50%). The differences were statistically significant
(P<0.05). Their administration depended on the patient’s
description of persistent pain despite diclofenac adminis-
tration. They include 8 doses of meperidine (50 mg each)
after LC and 40 doses of dextropropoxyphene (75 mg
each) in the study group and 20 doses of meperidine and
80 doses of dextropropoxyphene in the control group.
After LIHR, 0 doses of meperidine and 2 doses of dex-
tropropoxyphene were administered in the study group,
and 3 doses of meperidine and 12 doses of dextro-
propoxyphene were administered in the control group.
Figure 2. Postoperative visual analogue scale (VAS) scores in the
patients of the study group and control group after laparoscopic
inguinal hernia repair (LIHR).
Figure 1. Postoperative visual analogue scale (VAS) scores in the
patients of the study group and control group after laparoscopic
cholecystectomy (LC).308 JSLS(2003)7:305-310
Postoperative nausea was experienced in the study group
in 18 patients after LC (24%) and in 1 patient after LIHR
(7%); in the control group in 11 patients after LC (25%)
and in 2 patients after LIHR (12%). The differences were
not statistically significant (P>0.05). The nausea was man-
aged with metoclopramide or ondansetron in more per-
sistent cases. 
The mean duration of hospital stay was 2.1 days (range 1
to 7) for cholecystectomy and 1.4 days (range 1 to 4) for
hernia repair in the study group. It was 1.9 days (range 1
to 4) for LC and 1.5 days (range 1 to 3) for LIHR in the
control group.
The mean time of return to normal activity was 5.1 days
(range 4 to 10) after LC and 6.2 days (range 5 to 14) after
LIHR in the study group. It was 5.3 days (range 4 to 9)
for LC and 6.4 days (range 4 to 10) for LIHR in the con-
trol group.
DISCUSSION
Laparoscopic cholecystectomy reduces the incidence of
postoperative right upper quadrant pain seen after open
procedures.14,15 It has been reported that after laparo-
scopic cholecystectomy no analgesia was required by
26% of patients, nonnarcotic analgesia by 42%, and nar-
cotic analgesia by 32%.7
Our results have been compared separately for 2 differ-
ent laparoscopic procedures, ie, cholecystectomy and
inguinal hernia repair. The results are reported here in
the same article, and both evaluate the relief of pain com-
ing from the port-site wounds. More specifically, in our
study the use of ropivacaine increased the rate of no
analgesia required from 20% to 41% after laparoscopic
cholecystectomy and from 44% to 85% after laparoscopic
TAPP inguinal hernia repair. Likewise, it decreased the
rate of opioid requirement and the quantity, from 51% to
32% after laparoscopic cholecystectomy and from 50% to
7% after laparoscopic TAPP inguinal hernia repair.
Postoperative nausea and shoulder pain remained statis-
tically unchanged. However, it is important to note that in
this study after laparoscopic cholecystectomy, one third
of our patients with ropivacaine infiltration still required
opium analgesia; this indicates perhaps that the origin of
pain may have been other than at the port site. The port-
site wounds consist of the most usual cause of pain in the
immediate postoperative hours; other less common
sources of distress are visceral mainly from cholecystec-
tomy and shoulder tip pain attributed to diaphragmatic
stretching.5
Periportal peritoneal injection of a long-acting local anes-
thetic reduces immediate postoperative pain after laparo-
scopic cholecystectomy. The parietal peritoneum injury
at the port sites may be a source of pain. For this reason,
infiltration to around this level is preferable.16 This
approach was our policy.
In a recent review article,5 it was affirmed that regarding
pre- or postoperative wound injection, one is not more
effective than the other. However, Sarac et al17 suggest-
ed that preemptive injection is not as effective as post-
operative injection. Therefore, it seems that this is a
debatable issue. In this study, we preferred the preinci-
sional use to block sensory inflow at the periphery, pre-
venting the pain stimuli. It seems that recent reports11-13
support this preemptive local infiltration.
Intraperitoneal use of bupivacaine alone6 or in combina-
tion with normal saline8 in pain control after laparoscop-
ic cholecystectomy has not gained wide acceptance.
Also, instilling bupivacaine into the confined preperi-
toneal space has no effect on postoperative pain after
TAPP laparoscopic hernia repair, and its routine use can-
not be recommended.18
Some refinements in laparoscopic cholecystectomy tech-
niques have been made, but the use of the open
Hasson’s method for the initial peritoneal access has not
been widely accepted. Half of the bowel injury during
laparoscopic cholecystectomy has happened as a result
of a blind insertion of the Veress needle or the first tro-
car placement.19 We now routinely use the open method
under direct vision to avoid this and other rare inadver-
tent visceral or vessel injuries. However, this approach
using sutures for fascial repair may be a further source of
pain. The incidence of herniation through port sites has
not yet been accurately documented.
Also, the local anesthetic can be infused into a surgical
wound in day surgery inguinal hernia repair for pain
relief.20
Ropivacaine is a recently introduced long-acting local
anesthetic with lower toxicity, fewer side effects, and is
longer-lasting than bupivacaine. The duration of its
action is 8 to 10 hours. Preoperative local infiltration of
the inguinal wound for pain relief after open tension-free
hernia repair is an effective and safe method.21-23 The
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local anesthetic to increase the duration of their postop-
erative analgesic effect is debatable.24-26 
Despite pain control, postoperative nausea and vomiting
are common side effects after general anesthesia and sur-
gery, especially in patients undergoing laparoscopic pro-
cedures. The intravenous administration of metoclo-
pramide or especially ondansetron, as in our experience,
may be beneficial.27
CONCLUSION
Our study suggests that preincisional periportal infiltra-
tion by ropivacaine is a safe, effective, and affordable
method for pain relief after laparoscopic cholecystecto-
my or laparoscopic inguinal hernia repair. Its efficacy
diminishes or reduces the quantity of opioids required.
The VAS scores at 24 hours were similar for both laparo-
scopic procedures.
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